Alveolar Ridge Augmentation With Curcumin Combined With Xenograft
Horizontal Alveolar Bone Loss
About this trial
This is an interventional treatment trial for Horizontal Alveolar Bone Loss focused on measuring curcumin, xenograft, Piezoelectric, Alveolar Ridge Splitting
Eligibility Criteria
Inclusion Criteria:
- Male and female with age range 25-45 years.
- Patient with enough alveolar ridge height, suffering from missing single or multiple maxillary anterior and /or premolar with insufficient alveolar ridge buccolingual (BL) width that interfere with conventional straight forward implant placement. The minimum BL width included in the study will be 4-5 mm to facilitate ridge splitting and expansion.
- Systemically free from any diseases as evidenced by Burket's oral medicine health history questionnaire.
- Patient available during follow up periods.
Exclusion Criteria:
- Smokers.
- Pregnant and breast feeding females.
- Patient unwilling to comply to oral hygienic instructions.
- Patients under any medication or medical condition that affect the bone quality.
- Vulnerable groups. (e.g decisions impaired individual).
Sites / Locations
- faculty of dentistry Ain shams university
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
curcumin combined with particulate xenograft.
alveolar ridge splitting with use of particulate xenograft alone.
Curcumin will be used in combination with xenograft after ridge splitting surgery Curcumin is widely used in medicine due to medicinal properties, cost-effectiveness, and simple extraction from a turmeric plant that grows in different regions in the world. Recent evidences have shown that curcumin possesses multiple biological activities and pharmacological properties including anti-inflammation , antioxidation , anticancer , antimicrobial , and free radical scavenger effects
xenograft will be used alone after ridge splitting